Drug · DIN 02375915
CERTICAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since November 14, 2011.
- Drug Identification Number (DIN)
- 02375915
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Everolimus L04AH02
- Class
- Human
- Record last updated
- September 11, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EVEROLIMUS | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 14, 2011: NOC 12781New Drug Submission (NDS)
Other DINs named CERTICAN
- DIN 02375907 · Approved
- DIN 02375923 · Approved